HSCSW
HealthcareHeart Test Laboratories Inc - Warrants(15/06/2027)
$0.06-0.01 (-8.06%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving HSCSW Today?
No stock-specific AI insight has been generated for HSCSW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.03$0.18
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS$-1.09
Dividend Yield—
Dividend / Share—
ROE-3.8%
Profit Margin—
Debt / Equity—
Trading
Volume101
Avg Volume (10D)—
Shares Outstanding—
HSCSW News
18 articles- HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™Yahoo Finance·May 5, 2026
- HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders MeetingYahoo Finance·Apr 14, 2026
- HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System CategoryYahoo Finance·Mar 25, 2026
- HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor MeetingsYahoo Finance·Mar 24, 2026
- Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)Yahoo Finance·Mar 20, 2026
- HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·Mar 16, 2026
- HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowYahoo Finance·Oct 21, 2025
- HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial ResultsYahoo Finance·Sep 11, 2025
- Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live streamYahoo Finance·Aug 19, 2025
- HeartSciences Announces Conference Participation and Investor WebinarYahoo Finance·Aug 15, 2025
- HeartSciences Provides Business Update and Reports Fiscal 2025 Financial ResultsYahoo Finance·Jul 24, 2025
- HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithmYahoo Finance·Jun 5, 2025
- HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic StenosisYahoo Finance·Jun 4, 2025
- Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP ValueYahoo Finance·Jun 3, 2025
- HeartSciences signs first MyoVista Insights platform customerYahoo Finance·May 30, 2025
- HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial MilestoneYahoo Finance·May 29, 2025
- HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025Yahoo Finance·May 20, 2025
- Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live streamYahoo Finance·May 20, 2025
All 18 articles loaded
Price Data
Open$0.06
Previous Close$0.07
Day High$0.09
Day Low$0.06
52 Week High$0.18
52 Week Low$0.03
52-Week Range
$0.03$0.18
$0.06
Fundamentals
Market Cap—
P/E Ratio—
EPS$-1.09
Dividend Yield—
Dividend / Share—
ROE-3.8%
Profit Margin—
Debt / Equity—
Trading
Volume101
Avg Volume (10D)—
Shares Outstanding—
About Heart Test Laboratories Inc - Warrants(15/06/2027)
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.
HealthcareORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—